Differentiation-inducing factor-1, a morphogen of Dictyostelium, induces G1 arrest and differentiation of vascular smooth muscle cells

Circulation Research

Volumn 86, Issue 1, 2000, Pages 68-75

  Miwa, Yoshikazu ^b   Sasaguri, Toshiyuki ^a   Kosaka, Chiya ^b   Taba, Yoji ^b   Ishida, Akio ^b   Abumiya, Takeo ^b   Kubohara, Yuzuru ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NONE

Author keywords

Cell cycle; Cyclin; Differentiation; Differentiation inducing factor 1; Vascular smooth muscle cell

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; DIFFERENTIATION INDUCING FACTOR; MORPHOGEN; MYOSIN HEAVY CHAIN; RETINOBLASTOMA PROTEIN;

ARTICLE; ATHEROSCLEROSIS; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; ENZYME INHIBITION; GENE REPRESSION; HUMAN; HUMAN CELL; MITOGENICITY; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VASCULAR SMOOTH MUSCLE;

EID: 0033962834     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.86.1.68     Document Type: Article

References (35)

1. Morris HR, Taylor GW, Masento MS, Jermyn KA, Kay RR. Chemical structure of the morphogen differentiation inducing factor from Dictyostelium discoideum. Nature. 1987;328:811-841.
2. Suzuki T, Oka H, Okura A, Asahi K, Takahashi N. In vitro and in vivo effects of differanisole A on some tumor cells. J Antibiot (Tokyo). 1986;39:869-871.
3. Asahi K, Sakurai A, Takahashi N, Kubohara Y, Okamoto K, Tanaka Y. DIF-1, morphogen of Dictyostelium discoideum, induces the erythroid differentiation in murine and human leukemia cells. Biochem Biophys Res Commun. 1995;208:1036-1039.
4. Kubohara Y. DIF-1, putative morphogen of D. discoideum, suppresses cell growth and promotes retinoic acid-induced cell differentiation in HL-60. Biochem Biophys Res Commun. 1997;236:418-422.
5. Schwartz SM, Campbell GR, Campbell JH. Replication of smooth muscle cells in vascular disease. Circ Res. 1986;58:427-444.
6. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
7. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487-517.
8. Sasaguri T, Ishida A, Kosaka C, Nojima H, Ogata J. Phorbol ester inhibits the phosphorylation of the retinoblastoma protein without suppressing cyclin D-associated kinase in vascular smooth muscle cells. J Biol Chem. 1996;271:8345-8351.
9. Sdi1/Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem. 1997;272:10050-10057.
10. Planas-Silva MD, Weinberg RA. The restriction point and control of cell proliferation. Curr Opin Cell Biol. 1997;9:768-772.
11. 1 phase progression: cycling on cue. Cell. 1994;79: 551-555.
12. MAPK pathway. J Biol Chem. 1996;271: 20608-20616.
13. 1 progression in NIH 3T3 cells. Mol Cell Biol. 1995;15: 3654-3663.
14. Kip1. Mol Cell Biol. 1997;17:3850-3857.
15. ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem. 1995;270:23589-23597.
16. Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem. 1998;273:29864-29872.
17. S6K-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol. 1999;19:1346-1358.
18. Rovner AS, Murphy RA, Owens GK. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J Biol Chem. 1986;261:14740-14745.
19. Nagai R, Kuro-o M, Babij P, Periasamy M. Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem. 1989;264:9734-9737.
20. Aikawa M, Sakomura Y, Ueda M, Kimura K, Manabe I, Ishiwata S, Komiyama N, Yamaguchi H, Yazaki Y, Nagai R. Redifferentiation of smooth muscle cells after coronary angioplasty determined via myosin heavy chain expression. Circulation. 1997;96:82-90.
21. 1/S cyclin-dependent kinases. J Biol Chem. 1997;272:12738-12746.
22. Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol. 1997;173:233-236.
23. Cartel AL, Serfas MS, Tyner AL. p21-negative regulator of the cell cycle. Proc Soc Exp Biol Med. 1996;213:138-149.
24. 2-mediated cellular arrest and death. Cancer Res. 1996;56:475-479.
25. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 1994; 8:9-22.
26. Kip1) of cyclin-dependent kinase 4 activation. Cell. 1994;79:487-496.
27. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature. 1994;371:257-261.
28. Cocks BG, Vairo G, Bodrug SE, Hamilton JA. Suppression of growth factor-induced CYL1 cyclin gene expression by antiproliferative agents. J Biol Chem. 1992;267:12307-12310.
29. 1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J Biol Chem. 1998;273:14424-14429.
30. 1 cyclin expression. J Biol Chem. 1997;272:13816-13822.
31. 1 phase. J Biol Chem. 1998; 273:20156-20161.
32. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999;398:422-426.
33. Shtutman M, Zhurinsky J, Simcha I, Albanese C, Di'Amico M, Pestell R, Ben-Zeíev A. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA. 1999;96:5522-5527.
34. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science. 1995;267:1022~1024.
35. Kawata T, Shevchenko A, Fukuzawa M, Jermyn KA, Totty NF, Zhukovskaya NV, Sterling AE, Mann M, Williams JG. SH2 signaling in a lower eukaryote: a STAT protein that regulates stalk cell differentiation in Dictyostelium. Cell. 1997;89:909-916.